Vacuum-Induced Hemorrhage Control versus Uterine Balloon Tamponade for Management of Postpartum Hemorrhage

Files

Authors

Courtney Makris, Corewell Health West Resident
David Colombo, Corewell Health West

Description

Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality worldwide. Despite the use of first- and second-line PPH treatment modalities, the incidence of PPH continues to increase. This has prompted the need for the development of novel treatment options. Intrauterine balloon tamponade devices (UBT) are a common treatment option for PPH not responsive to first-line treatment. The Bakri balloon is a commonly used intrauterine balloon tamponade device, and the recent introduction of the Jada device, a vacuum-induced hemorrhage control device (VHD) offers a novel, effective option. The purpose of this research study is to compare these two intrauterine devices for the treatment of PPH to determine the most effective strategy by comparing maternal outcomes.

Publication Date

5-9-2025

Disciplines

Obstetrics and Gynecology

Recommended Citation

Makris C, Colombo D. Vacuum-induced hemorrhage control versus uterine balloon tamponade for management of postpartum hemorrhage. Presented at: Research Day Corewell Health West; 2025 May 9; Grand Rapids, MI.

Comments

2025 Research Day Corewell Health West, Grand Rapids, MI, May 9, 2025. Abstract 1766